200
Participants
Start Date
March 1, 2012
Primary Completion Date
April 28, 2014
Study Completion Date
June 28, 2018
TDF treatment
About 100 mothers treated with tenofovir from 30-32 weeks of pregnancy to the week 4 of postpartum, then observed to the end of the study at post-partum week 28, paired infants received standard HBV prophylaxis.
Hepatobiliary Disease Hospital of Jilin Province, Changchun
The Second Affiliated Hospital of the Southeast University, Nanjing
Southwest Hospital, Chongqing
Nanyang Central Hospital, Nanyang
The Fifth Hospital of Shijiazhuang, Shijiazhuang
Lead Sponsor
Collaborators (1)
Gilead Sciences
INDUSTRY
New Discovery LLC
INDUSTRY